PRKDC and acute myeloid leukemia: Importantly, addition of DNA-PK inhibitor V to mitoxantrone significantly increased apoptosis (%cPARP+) and thus alleviated mitoxantrone resistance for AML cells on or off stroma (Figure 2C1-2C2).